Cargando…

Transient plasma viral rebound after SARS-CoV-2 vaccination in an exceptional HIV-1 elite controller woman

BACKGROUND: Elite controllers are able to control viral replication without antiretroviral therapy. Exceptional elite controllers do not show disease progression for more than 25 years. Different mechanisms have been proposed and several elements of both innate and adaptive immunity are implicated....

Descripción completa

Detalles Bibliográficos
Autores principales:	Di Girolamo, L., Ferrara, M., Trevisan, G., Longo, B. M., Allice, T., Burdino, E., Alladio, F., Fantino, S., Di Perri, G., Calcagno, A., Bonora, S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10262927/ https://www.ncbi.nlm.nih.gov/pubmed/37312093 http://dx.doi.org/10.1186/s12985-023-02086-z

Ejemplares similares

Co-infection with other respiratory pathogens in COVID-19 patients
por: Calcagno, Andrea, et al.
Publicado: (2021)

Determinants of SARS-CoV-2 Contagiousness in Household Contacts of Symptomatic Adult Index Cases
por: Trunfio, Mattia, et al.
Publicado: (2022)

Diagnostic SARS-CoV-2 Cycle Threshold Value Predicts Disease Severity, Survival, and Six-Month Sequelae in COVID-19 Symptomatic Patients
por: Trunfio, Mattia, et al.
Publicado: (2021)

On the SARS-CoV-2 “Variolation Hypothesis”: No Association Between Viral Load of Index Cases and COVID-19 Severity of Secondary Cases
por: Trunfio, Mattia, et al.
Publicado: (2021)

Clinical Phenotype and Contagiousness of Early Breakthrough SARS-CoV-2 Infections after BNT162b2 COVID-19 mRNA Vaccine: A Parallel Cohort Study in Healthcare Workers
por: Trunfio, Mattia, et al.
Publicado: (2021)

Lowering SARS-CoV-2 viral load might affect transmission but not disease severity in secondary cases
por: Trunfio, Mattia, et al.
Publicado: (2021)

A(H1N1)pdm09 hemagglutinin D222G and D222N variants are frequently harbored by patients requiring extracorporeal membrane oxygenation and advanced respiratory assistance for severe A(H1N1)pdm09 infection
por: Ruggiero, Tina, et al.
Publicado: (2013)

Transient detectable viremia and the risk of viral rebound in patients from the Swiss HIV Cohort Study
por: Young, Jim, et al.
Publicado: (2015)

Risk for SARS-CoV-2 Infection in Healthcare Workers, Turin, Italy
por: Calcagno, Andrea, et al.
Publicado: (2021)

Transient viral replication during analytical treatment interruptions in SIV infected macaques can alter the rebound-competent viral reservoir
por: Immonen, Taina T., et al.
Publicado: (2021)

To rebound or not to rebound
por: Stahl, Bethany A, et al.
Publicado: (2017)

Patterns of Cerebrospinal Fluid Alzheimer’s Dementia Biomarkers in People Living with HIV: Cross-Sectional Study on Associated Factors According to Viral Control, Neurological Confounders and Neurocognition
por: Trunfio, Mattia, et al.
Publicado: (2022)

Concurrent and Subsequent Co-Infections of Clostridioides difficile Colitis in the Era of Gut Microbiota and Expanding Treatment Options
por: Trunfio, Mattia, et al.
Publicado: (2022)

A filter-based cross-sectional analysis of an HIV-positive, HAART-treated cohort in rural Burundi: pharmacokinetics, pharmacogenetics and viral load
por: Calcagno, A, et al.
Publicado: (2010)

Vesicular MicroRNA as Potential Biomarkers of Viral Rebound
por: Bazié, Wilfried Wenceslas, et al.
Publicado: (2022)

Viral and Symptom Rebound in Untreated COVID-19 Infection
por: Deo, Rinki, et al.
Publicado: (2022)

Nirmatrelvir–Ritonavir and Viral Load Rebound in Covid-19
por: Anderson, Annaliesa S., et al.
Publicado: (2022)

Viral suppression and viral rebound among young adults living with HIV in Canada
por: Palmer, Alexis, et al.
Publicado: (2018)

Case of Supra-pubic Lithotomy in a Woman—An Exceptional Case
por: Tait, Lawson
Publicado: (1884)

Urgent need of rapid tests for SARS CoV-2 antigen detection: Evaluation of the SD-Biosensor antigen test for SARS-CoV-2
por: Cerutti, Francesco, et al.
Publicado: (2020)

Viral Rebound Kinetics Correlate with Distinct HIV Antibody Features
por: Bartsch, Yannic C., et al.
Publicado: (2021)

Incidence of Viral Rebound After Treatment With Nirmatrelvir-Ritonavir and Molnupiravir
por: Wong, Grace Lai-Hung, et al.
Publicado: (2022)

Antibody and TLR7 Agonist Delay Viral Rebound in SHIV-Infected Monkeys
por: Borducchi, Erica N., et al.
Publicado: (2018)

Potential biomarkers: Predicting post-treatment viral rebound in rhesus macaques
por: Yang, Chenbo, et al.
Publicado: (2023)

Real-life Evidence of Lower Lung Virulence in COVID-19 Inpatients Infected with SARS-CoV-2 Omicron Variant Compared to Wild-Type and Delta SARS-CoV-2 Pneumonia
por: Trunfio, Mattia, et al.
Publicado: (2022)

An exceptionally large coronary artery aneurysm in a formerly healthy young woman
por: Du Pré, B.C., et al.
Publicado: (2015)

The risk of viral rebound in the year after delivery in women remaining on antiretroviral therapy
por: Huntington, Susie, et al.
Publicado: (2015)

Immunological biomarkers predict HIV-1 viral rebound after treatment interruption
por: Hurst, Jacob, et al.
Publicado: (2015)

994. Risk for Viral Rebound in the Era of U=U; A CNICS Analysis
por: Hansen, Blake, et al.
Publicado: (2020)

Rebound of shelf water salinity in the Ross Sea
por: Castagno, Pasquale, et al.
Publicado: (2019)

Severe rebound after cessation of fingolimod treated with ocrelizumab with coincidental transient aggravation: report of two cases
por: Schmidt, Stephan, et al.
Publicado: (2019)

Permanent control of HIV-1 pathogenesis in exceptional elite controllers: a model of spontaneous cure
por: Casado, Concepcion, et al.
Publicado: (2020)

BPS black holes, supersymmetry and orbits of exceptional groups
por: Ferrara, S.
Publicado: (1998)

Transient Viral Rebound in Children with Perinatally Acquired HIV-1 Induces a Unique Soluble Immunometabolic Signature Associated with Decreased CD4/CD8 Ratio
por: Tarancon-Diez, Laura, et al.
Publicado: (2023)

Blood–Brain Barrier Impairment in Patients Living with HIV: Predictors and Associated Biomarkers
por: Caligaris, Giulia, et al.
Publicado: (2021)

Predictions of time to HIV viral rebound following ART suspension that incorporate personal biomarkers
por: Conway, Jessica M., et al.
Publicado: (2019)

Multidrug-resistant HIV viral rebound during early syphilis: a case report
por: Giacomelli, Andrea, et al.
Publicado: (2020)

A multidimensional HIV-1 persistence model for clonal expansion and viral rebound in vitro
por: Eshetu, Amare, et al.
Publicado: (2021)

Remdesivir/tocilizumab: Rebound of HCV viral load and loss of anti-HBs: case report
Publicado: (2021)

Unified model of short- and long-term HIV viral rebound for clinical trial planning
por: Conway, Jessica M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1hg6ku880mhjgdvp81gh69q579